The Harvey L. Neiman Health Policy Institute® studies the value and role of radiology in evolving health care delivery and payment systems, including quality based approaches to care and the impact of medical imaging on overall health care costs. Neiman Institute research provides a foundation for evidence-based imaging policy to improve patient care and bolster efficient, effective use of health care resources.
Harvey L. Neiman Health Policy Institute is pleased to announce that it is part of a team that has been awarded a one-year R56 research grant from the National Institutes of Health entitled, “Comparative Effectiveness of Imaging Strategies in Acute Ischemic Stroke Based on Patient Profiles”. Read More
A new study from Harvey L. Neiman Health Policy Institute finds that over ¾ of Multiple Sclerosis (MS) patients face financial toxicity that often results in non-adherence to follow up care. This study is the first of its kind to evaluate financial toxicity in MS and whether financial strain is linked to patients foregoing the therapy and imaging follow-up prescribed in their treatment plan. Read More
The Harvey L. Neiman Health Policy Institute® studies the value and role of radiology in evolving health care delivery and payment systems, including quality based approaches to care and the impact of medical imaging on overall health care costs. Neiman Institute research provides a foundation for evidence-based imaging policy to improve patient care and bolster efficient, effective use of health care resources.
Read More
October 1, 2020 in Press Releases
Harvey L. Neiman Health Policy Institute is pleased to announce that it is part of a team that has been awarded a one-year R56 research grant from the National Institutes of Health entitled, “Comparative Effectiveness of Imaging Strategies in Acute Ischemic Stroke Based on Patient Profiles”. Read More
September 8, 2020 in Press Releases
A new study from Harvey L. Neiman Health Policy Institute finds that over ¾ of Multiple Sclerosis (MS) patients face financial toxicity that often results in non-adherence to follow up care. This study is the first of its kind to evaluate financial toxicity in MS and whether financial strain is linked to patients foregoing the therapy and imaging follow-up prescribed in their treatment plan. Read More
August 20, 2020 in Press Releases
Researchers supported by the Neiman Health Policy Institute (NPHI) find that higher numbers of paid malpractice claims are associated with a subsequent increase in advanced imaging utilization. The Journal of American College of Radiology study examined the quantity and cost of malpractice claims and Medicare imaging utilization at the state and national level. Read More
July 10, 2020 in Press Releases
Imaging today plays essential roles in the management of almost all non-cutaneous cancers, influencing diagnosis, assessment of prognosis, treatment selection, and therapeutic monitoring. This new Journal of the American College of Radiology (JACR) study characterizes national trends in oncologic imaging utilization. Read More
July 8, 2020 in Press Releases
The COVID-19 pandemic has quickly spread across all 50 United States. This new Harvey L. Neiman Health Policy Institute study, published online in the Journal of American College of Radiology, aimed to characterize the recent declines in non-invasive diagnostic imaging volumes at community practices. Read More